Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Posts Exciting Clinical Data Regarding Trokendi XR(TM) and Oxtellar XR(TM) on the Company Website Supernus to Present at Piper Jaffray Healthcare Conference in December Supernus Pharmaceuticals Reports Third Quarter 2013 Financial Results Supernus Announces Third Quarter 2013 Earnings Conference Call and Webcast Supernus Announces Release of Exciting New Clinical Data on Trokendi XR(TM) Supernus Launches Trokendi XR(TM) in the United States Supernus to Present at Two Investor Conferences in September Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR(TM) Supernus Pharmaceuticals Reports Second Quarter 2013 Financial Results Supernus Sues Watson for Infringement of Oxtellar XR(TM) Patents Pagination First page « first Previous page ‹ previous … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page next › Last page last »